Combigene

Activities: Research & Development Pharmaceutical

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Analysis

CombiGene and CGT Catapult collaborate on assays for CG01

CombiGene will now integrate the analytical assays into its production process
Manufacturing

CombiGene and Cobra sign agreement for GMP plasmid production

The agreement is part of preparations for GMP production of material for the first clinical study of CG01
Research & Development

CombiGene receives €3.3m from Horizon 2020

Horizon 2020, the EU framework programme for research and development, will invest in CombiGene’s ongoing development and commercialisation of its gene therapy project focussing on difficult-to-treat epilepsy
Manufacturing

Development of manufacturing process for novel gene therapy

CombiGene and Cell and Gene Therapy Catapult (CGT Catapult) have signed an agreement to develop a manufacturing process for a unique gene therapy to treat epilepsy
Subscribe now